Edwards Catheter Wins FDA Approval
- Share via
Dow Jones
Edwards Lifesciences Corp. in Irvine received Food and Drug Administration approval to begin selling its Vantex central venous catheter. Shares of the company, which develops products and services to treat late-stage cardiovascular disease, rose $1.19, or nearly 7%, to $19, on the New York Stock Exchange.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
